Citadel Advisors’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,600
| Closed | -$703K | – | 12587 |
|
|
2025
Q3 | $703K | Sell |
16,600
-2,600
| -14% | -$98K | ﹤0.01% | 8323 |
|
|
2025
Q2 | $597K | Sell |
19,200
-300
| -2% | -$8.12K | ﹤0.01% | 8221 |
|
|
2025
Q1 | $479K | Sell |
19,500
-10,400
| -35% | -$289K | ﹤0.01% | 8565 |
|
|
2024
Q4 | $855K | Buy |
29,900
+9,400
| +46% | +$261K | ﹤0.01% | 7384 |
|
|
2024
Q3 | $546K | Buy |
20,500
+14,600
| +247% | +$379K | ﹤0.01% | 8080 |
|
|
2024
Q2 | $151K | Sell |
5,900
-12,100
| -67% | -$271K | ﹤0.01% | 10336 |
|
|
2024
Q1 | $381K | Buy |
18,000
+8,600
| +91% | +$160K | ﹤0.01% | 8960 |
|
|
2023
Q4 | $168K | Sell |
9,400
-1,800
| -16% | -$28K | ﹤0.01% | 10218 |
|
|
2023
Q3 | $170K | Sell |
11,200
-8,500
| -43% | -$138K | ﹤0.01% | 10164 |
|
|
2023
Q2 | $339K | Buy |
19,700
+4,600
| +30% | +$67.7K | ﹤0.01% | 8777 |
|
|
2023
Q1 | $198K | Buy |
15,100
+9,300
| +160% | +$119K | ﹤0.01% | 10204 |
|
|
2022
Q4 | $70.3K | Sell |
5,800
-11,800
| -67% | -$142K | ﹤0.01% | 11697 |
|
|
2022
Q3 | $244K | Buy |
+17,600
| New | +$354K | ﹤0.01% | 10018 |
|
|
2022
Q2 | – | Sell |
-26,400
| Closed | -$564K | – | 12803 |
|
|
2022
Q1 | $564K | Buy |
26,400
+14,400
| +120% | +$278K | ﹤0.01% | 9095 |
|
|
2021
Q4 | $244K | Sell |
12,000
-14,100
| -54% | -$284K | ﹤0.01% | 11417 |
|
|
2021
Q3 | $582K | Buy |
26,100
+14,000
| +116% | +$361K | ﹤0.01% | 9499 |
|
|
2021
Q2 | $344K | Sell |
12,100
-900
| -7% | -$24.5K | ﹤0.01% | 10929 |
|
|
2021
Q1 | $294K | Buy |
13,000
+4,000
| +44% | +$97.9K | ﹤0.01% | 10904 |
|
|
2020
Q4 | $212K | Buy |
+9,000
| New | +$182K | ﹤0.01% | 9653 |
|
|
2020
Q3 | – | Sell |
-16,900
| Closed | -$324K | – | 10028 |
|
|
2020
Q2 | $324K | Buy |
+16,900
| New | +$358K | ﹤0.01% | 7785 |
|
|
2017
Q4 | – | Sell |
-9,500
| Closed | -$216K | – | 7925 |
|
|
2017
Q3 | $216K | Buy |
+9,500
| New | +$191K | ﹤0.01% | 6572 |
|
|
2016
Q4 | – | Sell |
-16,300
| Closed | -$286K | – | 7211 |
|
|
2016
Q3 | $286K | Buy |
+16,300
| New | +$246K | ﹤0.01% | 5742 |
|
|
2015
Q4 | – | Sell |
-4,400
| Closed | -$43K | – | 8694 |
|
|
2015
Q3 | $43K | Buy |
4,400
+2,100
| +91% | +$21.9K | ﹤0.01% | 7677 |
|
|
2015
Q2 | $26K | Buy |
2,300
+1,800
| +360% | +$19.1K | ﹤0.01% | 8033 |
|
|
2015
Q1 | $5K | Buy |
+500
| New | +$5.51K | ﹤0.01% | 8312 |
|
Other funds holding AORT
NAMI
VCM
PA
FAM
JIC
CCA
Citadel Advisors's AORT Position: Q1 2026 in Review
Citadel Advisors increased its Artivion (AORT) stake by 164% in Q1 2026, buying an estimated $1.74M and bringing the position to 70,869 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5542.
Citadel Advisors first reported a position in AORT in Q3 2013 and has held it in 39 quarters since. The position peaked at $4.76M in Q2 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.
- Citadel Advisors held 70,869 shares of Artivion worth $2.6M as of Q1 2026.
- Citadel Advisors bought 43,990 Artivion shares in Q1 2026, an estimated $1.74M.
- Artivion made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5542 holding.
- Citadel Advisors first reported a position in Artivion in Q3 2013 and has held it in 39 quarters since.
- Citadel Advisors's Artivion position peaked at $4.76M in Q2 2025.
- 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.